Medicines Reaches New 52-Week High (MDCO)

NEW YORK (TheStreet) -- Medicines (Nasdaq:MDCO) hit a new 52-week high Tuesday as it is currently trading at $22.98, above its previous 52-week high of $22.82 with 673,091 shares traded as of 1:55 p.m. ET. Average volume has been 355,000 shares over the past 30 days.

Medicines has a market cap of $1.2 billion and is part of the health care sector and drugs industry. Shares are up 16.6% year to date as of the close of trading on Monday.

The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. The company has a P/E ratio of 10.7, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

• Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Medicines as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full Medicines Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

For more information on Medicines click any of the following:

• Medicines Stock Price

• Medicines Analyst Ratings

• Medicines Key Stats & Profile

• Medicines Earnings

• Medicines Ratio Comparison

• Medicines Growth Rates

• Medicines Balance Sheet

• Medicines Cash Flow

• Medicines Income Statement